

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+7.62%
-0.96%
+11.09%
-1.75%
+4.34%
EBS
Emergent Biosolution
$9.69
Strengths

Trading below its fair value
Risk Analysis

Earnings are forecast to decrease

Investors losing their confidence
Chart
$8.94 (+8.39%)
$5.64 (+71.81%)
$6.33 (+53.08%)
$11 (-11.91%)
EBS has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

EBS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to decrease

Trading below its fair value
![]()
EBS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
EBS Street view is not attractive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayEBS Earnings
The TTM reflects 12-month period, providing review of EBS financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
CING
3.76
-2.59%
VKTX
35.93
+4.39%
SNY
51.41
-0.45%
VTRS
10.42
+0.68%
PFE
24.77
-0.02%
What is EBS current stock price?
What are EBS stock strengths?
What risks are associated with EBS stock?
When is EBS next earnings report?
What is EBS market cap and volume?
What is EBS's current Stock IQ?
Should I buy EBS stock right now?
Is EBS a Strong Buy right now?
What does a 'Strong Buy' rating mean for EBS?
What does a 'Strong Sell' rating mean for EBS?
What factors influence EBS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+7.62%
-0.96%
+11.09%
-1.75%
+4.34%
EBS
Emergent Biosolution
Current Price
$9.69
Stock Insights
Strengths

Trading below its fair value
Risk Analysis

Earnings are forecast to decrease

Investors losing their confidence
Linked to EBS
CING
3.76
-2.59%
VKTX
35.93
+4.39%
SNY
51.41
-0.45%
VTRS
10.42
+0.68%
PFE
24.77
-0.02%
Chart
$8.94 (+8.39%)
$5.64 (+71.81%)
$6.33 (+53.08%)
$11 (-11.91%)
EBS Analysts Opinion
EBS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to decrease

Trading below its fair value
![]()
EBS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
EBS Street view is not attractive and have negative views on the near-term outlook
EBS has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
EBS Earnings
The TTM data reflects the most recent 12-month period, providing overview of EBS financial performance.
EBS Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
EBS Latest Analysis
Emergent BioSolutions EVP Sold $306K In Company Stock. Making a noteworthy insider sell on October 16 EBS) is reported in the latest SEC filing.United States Securities and Exchange Commission on Thursday. The total transaction value is $306080.At Friday morning Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product MCM Products and Services segment. The Commercial Product Segment consisting
Fri Oct 17, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.